Fox Chase Therapeutics Discovery, Inc. (FCTDI) is a science-based company dedicated to the design, development, and evaluation of new drugs for potential use in human therapy. With a focus on translational research programs, FCTDI applies cutting-edge pharmacological screening, computational methods, chemical biology, and laboratory medicinal chemistry to pursue the treatment of human disease.
Through collaboration with scientists who share their mission, FCTDI brings distinctive value to their partners by fostering innovation, creativity, and the development of new intellectual property. With access to a vast collection of reagents and starting materials, FCTDI accelerates lead optimization, enabling faster progress in the discovery of new therapeutics.
Generated from the website